“Putting Big Bad Pharma Back on Trial in the COVID-19 Era”
(an article by Rebecca Strong)
A Post-Woke subscriber named Chris recently sent me a well-documented, evidence-based article by Rebecca Strong called “Putting Big Bad Pharma Back on Trial in the COVID-19 Era” and I’d like to pass it on to you!
Excerpt:
When the New England Journal of Medicine (NEJM) published 73 studies of new drugs over the course of a single year, they found that a staggering 82% of them had been funded by the pharmaceutical company selling the product, 68% had authors who were employees of that company, and 50% had lead researchers who accepted money from a drug company. According to 2013 research conducted at the University of Arizona College of Law, even when pharma companies aren’t directly funding the research, company stockholders, consultants, directors, and officers are almost always involved in conducting them. Unfortunately, this trend shows no sign of slowing down. The number of clinical trials funded by the pharmaceutical industry has been climbing every year since 2006, according to a John Hopkins University report, while independent studies have been harder to find.